Literature DB >> 30348686

Geranylgeraniol Induces PPARγ Expression and Enhances the Biological Effects of a PPARγ Agonist in Adipocyte Lineage Cells.

Takuma Matsubara1, Nana Takakura1, Mariko Urata1, Yuya Muramatsu1, Makoto Tsuboi1, Kazuma Yasuda1, William N Addison2, Min Zhang3, Kou Matsuo3, Chihiro Nakatomi1, Yukiyo Shigeyama-Tada4, Takeshi Kaneuji5, Atsuko Nakamichi6, Shoichiro Kokabu7.   

Abstract

BACKGROUND: The global incidence of diabetes mellitus (DM) has risen precipitously, even in middle- and low-income countries. Peroxisome proliferator-activated receptor γ (PPARγ) plays an important role in the control of cellular glucose metabolism. Activation of PPARγ beneficially results in increased insulin sensitivity. However, the expression of PPARγ is reduced by obesity and several nutritional factors. Here we examined the effect of geranylgeraniol (GGOH), a bioactive compound found naturally in fruits, vegetables, and grains, on the expression and activation of PPARγ.
MATERIALS AND METHODS: C3H10T1/2 mouse embryonic fibroblasts and 3T3-L1 pre-adipocytes were used as in vitro models of adipocyte differentiation and function. Quantitative reverse-transcriptase polymerase chain reaction, western blotting, Oil Red O staining, and luciferase assay were performed to respectively assess mRNA expression, protein levels, lipid droplet formation and transcriptional activity.
RESULTS: GGOH increased the expression of PPARγ in adipocyte lineage cells. GGOH also enhanced adipogenesis induced by rosiglitazone, a thiazolidinedione class PPARγ agonist.
CONCLUSION: GGOH induces PPARγ expression and enhances the biological effects of a PPARγ agonist in adipocyte lineage cells. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Diabetes; adipogenesis; antidiabetic drug; geranylgeranylation; statin

Mesh:

Substances:

Year:  2018        PMID: 30348686      PMCID: PMC6365726          DOI: 10.21873/invivo.11384

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  33 in total

Review 1.  The PPARs: from orphan receptors to drug discovery.

Authors:  T M Willson; P J Brown; D D Sternbach; B R Henke
Journal:  J Med Chem       Date:  2000-02-24       Impact factor: 7.446

2.  Ginsenoside 20S-protopanaxatriol (PPT) activates peroxisome proliferator-activated receptor gamma (PPARgamma) in 3T3-L1 adipocytes.

Authors:  Kyu Lee Han; Myeong Ho Jung; Jong Hee Sohn; Jae-Kwan Hwang
Journal:  Biol Pharm Bull       Date:  2006-01       Impact factor: 2.233

Review 3.  Targeting Ras and Rho GTPases as opportunities for cancer therapeutics.

Authors:  Katharine Walker; Michael F Olson
Journal:  Curr Opin Genet Dev       Date:  2005-02       Impact factor: 5.578

4.  Emodin with PPARgamma ligand-binding activity promotes adipocyte differentiation and increases glucose uptake in 3T3-Ll cells.

Authors:  Ying Yang; Wenbin Shang; Libin Zhou; Boren Jiang; Hua Jin; Mingdao Chen
Journal:  Biochem Biophys Res Commun       Date:  2006-12-06       Impact factor: 3.575

5.  Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome.

Authors:  Joost Frenkel; Ger T Rijkers; Saskia H L Mandey; Sandra W M Buurman; Sander M Houten; Ronald J A Wanders; Hans R Waterham; Wietse Kuis
Journal:  Arthritis Rheum       Date:  2002-10

6.  Ginsenoside Rb1 promotes adipogenesis in 3T3-L1 cells by enhancing PPARgamma2 and C/EBPalpha gene expression.

Authors:  Wenbin Shang; Ying Yang; Boren Jiang; Hua Jin; Libin Zhou; Shangquan Liu; Mingdao Chen
Journal:  Life Sci       Date:  2006-11-28       Impact factor: 5.037

7.  Protein phosphatase magnesium-dependent 1A-mediated inhibition of BMP signaling is independent of Smad dephosphorylation.

Authors:  Shoichiro Kokabu; Junya Nojima; Kazuhiro Kanomata; Satoshi Ohte; Tetsuya Yoda; Toru Fukuda; Takenobu Katagiri
Journal:  J Bone Miner Res       Date:  2010-03       Impact factor: 6.741

8.  Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.

Authors:  Naveed Sattar; David Preiss; Heather M Murray; Paul Welsh; Brendan M Buckley; Anton J M de Craen; Sreenivasa Rao Kondapally Seshasai; John J McMurray; Dilys J Freeman; J Wouter Jukema; Peter W Macfarlane; Chris J Packard; David J Stott; Rudi G Westendorp; James Shepherd; Barry R Davis; Sara L Pressel; Roberto Marchioli; Rosa Maria Marfisi; Aldo P Maggioni; Luigi Tavazzi; Gianni Tognoni; John Kjekshus; Terje R Pedersen; Thomas J Cook; Antonio M Gotto; Michael B Clearfield; John R Downs; Haruo Nakamura; Yasuo Ohashi; Kyoichi Mizuno; Kausik K Ray; Ian Ford
Journal:  Lancet       Date:  2010-02-16       Impact factor: 79.321

Review 9.  Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists.

Authors:  Christian Grommes; Gary E Landreth; Michael T Heneka
Journal:  Lancet Oncol       Date:  2004-07       Impact factor: 41.316

10.  Phloretin enhances adipocyte differentiation and adiponectin expression in 3T3-L1 cells.

Authors:  Meryl Hassan; Claire El Yazidi; Jean-François Landrier; Denis Lairon; Alain Margotat; Marie-Josèphe Amiot
Journal:  Biochem Biophys Res Commun       Date:  2007-07-16       Impact factor: 3.575

View more
  4 in total

Review 1.  Therapeutic potential of PPARγ natural agonists in liver diseases.

Authors:  Liwei Wu; Chuanyong Guo; Jianye Wu
Journal:  J Cell Mol Med       Date:  2020-02-07       Impact factor: 5.310

Review 2.  Adipocyte Biology from the Perspective of In Vivo Research: Review of Key Transcription Factors.

Authors:  Maria N Evseeva; Maria S Balashova; Konstantin Y Kulebyakin; Yury P Rubtsov
Journal:  Int J Mol Sci       Date:  2021-12-28       Impact factor: 5.923

3.  Olive Leaf Extract Supplementation Combined with Calorie-Restricted Diet on Reducing Body Weight and Fat Mass in Obese Women: Result of a Randomized Control Trial.

Authors:  Fatemeh Haidari; Forough Shayesteh; Majid Mohammad-Shahi; Mohammad-Taha Jalali; Kambiz Ahmadi-Angali
Journal:  Clin Nutr Res       Date:  2021-10-31

4.  Beneficial effect of dietary geranylgeraniol on glucose homeostasis and bone microstructure in obese mice is associated with suppression of proinflammation and modification of gut microbiome.

Authors:  Eunhee Chung; Moamen M Elmassry; Jay J Cao; Gurvinder Kaur; Jannette M Dufour; Abdul N Hamood; Chwan-Li Shen
Journal:  Nutr Res       Date:  2021-07-09       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.